Performance and Cost-Efficiency of an MPT64 Assay for Detecting Mycobacterium tuberculosis Complex in a Setting With Frequent Nontuberculous Mycobacteria Isolation
Journal of Korean Medical Science · 2025
DOI: 10.3346/jkms.2026.41.e9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Korean Medical Science, 2025. Verfasst von Hui-Jin Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Seoul Medical Center, Seoul, Korea. Hauptthemen laut MEDLINE: Antigens, Bacterial, Mycobacterium tuberculosis, Nontuberculous Mycobacteria, Tuberculosis. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute, Samsung Medical Center, Sungkyunkwan University.
Abstract (Originalsprache)
BACKGROUND: Rapid and accurate detection of Mycobacterium tuberculosis complex (MTBC) in acid-fast bacilli (AFB)-positive cultures is crucial for effective patient management and transmission control. This study assessed the diagnostic performance and cost-efficiency of the Bioline MPT64 assay for detecting MTBC in AFB-positive cultures in a setting with frequent nontuberculous mycobacteria (NTM) isolation. METHODS: Between August 2024 and February 2025, AFB-positive cultures were tested in parallel using the Bioline MPT64 assay and real-time polymerase chain reaction (PCR). The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the Bioline MPT64 assay were calculated using real-time PCR as the reference standard. Cost-efficiency of diagnostic strategies incorporating the Bioline MPT64 assay was also evaluated. RESULTS: Based on real-time PCR results, among 494 AFB-positive cultures, 192 (38.9%) were MTBC-positive, 299 (60.5%) were NTM-positive, 2 (0.4%) were positive for both MTBC and NTM, and 1 (0.2%) was negative for both. The Bioline MPT64 assay exhibited a sensitivity of 99.0% (192/194), specificity of 100% (300/300), PPV of 100% (192/192), and NPV of 99.3% (300/302). Two false-negative results occurred in MTBC-NTM co-positive cultures. Using the Bioline MPT64 assay alone could reduce costs by 66.7% compared to real-time PCR alone but carries a risk of missing approximately 1.0% of MTBC-positive cultures. A stepwise strategy-initial screening with the Bioline MPT64 assay followed by real-time PCR for MPT64-negative cultures-could offer diagnostic accuracy comparable to real-time PCR alone but result in only a modest 5.5% cost reduction. CONCLUSION: The Bioline MPT64 assay shows strong concordance with real-time PCR and offers substantial cost savings when used alone, though it may miss MTBC-NTM co-positive cultures. PCR confirmation of MPT64-negative results mitigates this risk but provides only modest cost savings in NTM-prevalent settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Seoul Medical Center, Seoul, Korea.
- Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
- Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. yiy00@naver.com.
- Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. voltaire0925@gmail.com.
- Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Medical Device Management and Research, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Korea.
ORCID-Profile: Hui-Jin Yu, Jung-Ah Kim, Hyun Mi Song, Kyoung Ah Lee, Heejung Kim, In Young Yoo, Tae Yeul Kim, Hee Jae Huh
Förderung
- Korea Health Industry Development Institute
- Samsung Medical Center, Sungkyunkwan University
Zitieren
APA
Yu, H. J., Kim, J. A., Song, H. M., Lee, K. A., Kim, H., Yoo, I. Y., Kim, T. Y., & Huh, H. J. (2025). Performance and Cost-Efficiency of an MPT64 Assay for Detecting Mycobacterium tuberculosis Complex in a Setting With Frequent Nontuberculous Mycobacteria Isolation. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2026.41.e9
Vancouver
Yu HJ, Kim JA, Song HM, Lee KA, Kim H, Yoo IY, et al. Performance and Cost-Efficiency of an MPT64 Assay for Detecting Mycobacterium tuberculosis Complex in a Setting With Frequent Nontuberculous Mycobacteria Isolation. Journal of Korean Medical Science. 2025. doi:10.3346/jkms.2026.41.e9
BibTeX
@article{Yu2025,
author = {Yu, Hui-Jin and Kim, Jung-Ah and Song, Hyun Mi and Lee, Kyoung Ah and Kim, Heejung and Yoo, In Young and Kim, Tae Yeul and Huh, Hee Jae},
title = {Performance and Cost-Efficiency of an MPT64 Assay for Detecting Mycobacterium tuberculosis Complex in a Setting With Frequent Nontuberculous Mycobacteria Isolation},
journal = {Journal of Korean Medical Science},
year = {2025},
doi = {10.3346/jkms.2026.41.e9}
}
EUVIMED